CDRE株価 $33.40 · 時価総額 $1.4bn
CADRE HOLDINGS, INC.
Orthopedic, Prosthetic & Surgical Appliances & Supplies法執行機関や軍事原子力市場向けに防護装備を製造販売し製品の買い替えや技術革新により収益を得る
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $483m | $568m | $610m |
| 成長率 | — | 17.6% | 7.5% |
| 総利益 | $201m | $233m | $260m |
| 総利益率 | 41.6% | 41.1% | 42.5% |
| 販管費 | $141m | $158m | $183m |
| 販管費率 | 29.1% | 27.9% | 30.0% |
| 営利 | $57m | $67m | $67m |
| 営利率 | 11.7% | 11.8% | 11.0% |
| 純利益 | $39m | $36m | $44m |
| PSR | 2.92x | 2.48x | 2.31x |
| PGPR | 7.0x | 6.0x | 5.4x |
| PER | 36.4x | 39.0x | 31.9x |
| PBR | 7.14x | 4.52x | 4.43x |
| ネットキャッシュ | — | $-98m | $-187m |
| EV/EBITDA | 21.4x | 18.1x | 18.6x |
| Rule of 40 | — | 29.4% | 18.5% |
| セールス効率 | — | 184.0% | 105.4% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
